Select a Size
| Size/SKU | Availability | Price |
|---|---|---|
100 mg | Please contact Customer Service for Availability | 1 840,00 CZK 1 508,80 CZK |
250 mg | Please contact Customer Service for Availability | 3 010,00 CZK 2 468,20 CZK |
500 mg | Please contact Customer Service for Availability | 5 890,00 CZK 4 829,80 CZK |
1 g | Please contact Customer Service for Availability | 7 950,00 CZK 6 519,00 CZK |
About This Item
1 508,80 CZK
List Price1 840,00 CZKSave 18%biological source
egg yolk
Quality Segment
type
Type XI-E
assay
≥99%
form
solution
concentration
100 mg/mL in chloroform
functional group
phospholipid
lipid type
phosphoglycerides
storage temp.
−20°C
SMILES string
[P](=O)([O-])(OC[C@H](OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)COC(=O)CCCCCCCCCCCCCCC)OCC[N+](C)(C)C
InChI
1S/C42H80NO8P/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-33-35-42(45)51-40(39-50-52(46,47)49-37-36-43(3,4)5)38-48-41(44)34-32-30-28-26-24-22-19-17-15-13-11-9-7-2/h14,16,20-21,40H,6-13,15,17-19,22-39H2,1-5H3/b16-14-,21-20-/t40-/m1/s1
InChI key
JLPULHDHAOZNQI-ZTIMHPMXSA-N
Application
<li><strong>Fabrication of Microalgae Oil Vesicles for Drug Delivery Applications:</strong> This study highlights the use of L-a-Phosphatidylcholine in creating microalgae oil vesicles, showing promise for encapsulating and delivering hydrophobic drugs effectively (Lin YC et al., 2024).</li>
<li><strong>Terpenes-Modified Lipid Nanosystems for Temozolomide, Improving Cytotoxicity against Glioblastoma Human Cancer Cells In Vitro:</strong> L-a-Phosphatidylcholine is employed to formulate terpene-modified lipid nanosystems, enhancing the solubility and bioactivity of temozolomide for glioblastoma treatment (Pashirova TN et al., 2023).</li>
<li><strong>Mitochondria-Targeted Lipid Nanoparticles Loaded with Rotenone as a New Approach for the Treatment of Oncological Diseases:</strong> Utilizing L-a-Phosphatidylcholine, this research developed mitochondria-targeted lipid nanoparticles, potentially offering a novel strategy for cancer therapy (Vasileva L et al., 2023).</li>
</ul>
Biochem/physiol Actions
Preparation Note
1 of 1
This Item | |||
|---|---|---|---|
| description egg yolk, Type XI-E, 100 mg/mL in chloroform, ≥99%, solution | description egg yolk, ~60% (TLC) | description egg yolk, Type XIII-E, 100 mg/mL in ethanol, solution | description from soybean, Type II-S, 14-29% choline basis |
| assay ≥99% | assay - | assay ≥99% (TLC) | assay - |
| biological source egg yolk | biological source egg yolk | biological source egg yolk | biological source soybean |
| functional group phospholipid | functional group phospholipid | functional group phospholipid | functional group phospholipid |
| storage temp. −20°C | storage temp. −20°C | storage temp. −20°C | storage temp. 2-8°C |
| form solution | form solid | form solution | form powder or solid |
| Quality Level 200 | Quality Level 200 | Quality Level 200 | Quality Level 200 |
Still not finding the right product?
Explore all of our products under L-α-Phosphatidylcholine
Signal Word
Danger
Hazard Codes
Precautionary Statements
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 3
Target Organs
Central nervous system, Liver,Kidney
Storage Class
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
WGK
WGK 3
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
PPE (personal protective equipment)
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
Regulatory Listings
Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.
67-66-3
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.


